IRIS UniCatt

Bria, Pietro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.592
EU - Europa 5.986
AS - Asia 4.372
SA - Sud America 781
AF - Africa 109
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.423
DE - Germania 2.168
SG - Singapore 2.035
CN - Cina 1.155
IT - Italia 897
SE - Svezia 731
BR - Brasile 643
UA - Ucraina 605
FR - Francia 552
VN - Vietnam 356
GB - Regno Unito 303
IE - Irlanda 202
IN - India 160
FI - Finlandia 142
ID - Indonesia 139
RU - Federazione Russa 124
JP - Giappone 88
BD - Bangladesh 87
CA - Canada 71
PL - Polonia 69
TR - Turchia 67
MX - Messico 59
HK - Hong Kong 53
AR - Argentina 48
NL - Olanda 45
AU - Australia 30
IQ - Iraq 29
ES - Italia 27
BE - Belgio 26
ZA - Sudafrica 25
CI - Costa d'Avorio 22
SA - Arabia Saudita 21
IR - Iran 19
KR - Corea 18
MA - Marocco 16
VE - Venezuela 16
EC - Ecuador 15
PK - Pakistan 15
CO - Colombia 14
EG - Egitto 14
PY - Paraguay 14
CH - Svizzera 13
AT - Austria 12
CL - Cile 12
IL - Israele 12
LT - Lituania 11
PE - Perù 11
PH - Filippine 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
TW - Taiwan 9
UZ - Uzbekistan 9
JM - Giamaica 8
JO - Giordania 8
NP - Nepal 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
LB - Libano 7
AL - Albania 6
DZ - Algeria 6
MY - Malesia 6
RO - Romania 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
NO - Norvegia 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
LK - Sri Lanka 4
TH - Thailandia 4
A1 - Anonimo 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
MC - Monaco 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AD - Andorra 1
AG - Antigua e Barbuda 1
Totale 17.856
Salva come PNG Salva come JPEG
Città #
Singapore 1.116
Chandler 861
Ashburn 780
San Jose 574
Jacksonville 333
San Mateo 245
Dublin 198
Beijing 187
Nanjing 183
Milan 179
Wilmington 158
New York 124
Nürnberg 124
Dearborn 121
Jakarta 121
Ho Chi Minh City 120
Los Angeles 120
Woodbridge 120
Rome 108
Bremen 106
Lauterbourg 103
Hanoi 101
Houston 101
Hefei 91
Redwood City 90
Boston 85
Ann Arbor 77
Nanchang 77
Seattle 74
Moscow 69
Lawrence 68
Tokyo 67
Frankfurt am Main 66
São Paulo 60
Munich 54
University Park 53
Marseille 48
Princeton 48
Norwalk 46
Hong Kong 45
Mountain View 44
Paris 42
Lancaster 40
Dallas 37
Buffalo 36
Fairfield 36
Boardman 33
Hebei 33
Santa Clara 33
Kent 32
Cattolica 31
Guangzhou 30
Kunming 30
Shanghai 30
Atlanta 28
Shenyang 28
Warsaw 28
Tianjin 27
Brooklyn 26
Cambridge 26
Fremont 26
Hangzhou 26
Izmir 25
Abidjan 22
Changsha 22
Falls Church 22
Helsinki 22
Kraków 22
Chennai 21
Columbus 21
Philadelphia 21
Andover 20
Da Nang 20
Düsseldorf 20
Rio de Janeiro 20
Brussels 19
Mexico City 19
Bologna 18
Chicago 18
London 18
The Dalles 18
Menlo Park 17
Montreal 17
Phoenix 17
Porto Alegre 17
Jiaxing 16
Orem 16
Belo Horizonte 15
Memphis 15
Pune 15
Augusta 14
Baghdad 14
Brasília 14
Haiphong 14
Stockholm 14
Detroit 13
Johannesburg 13
Saint-Ouen-l'Aumone 13
Bexley 12
Denver 12
Totale 8.669
Salva come PNG Salva come JPEG
Nome #
Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions 292
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 270
Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial. 269
Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial 267
Plasma cortisol levels and resilience in depressed patients 265
Programma di trattamento integrato in regime di day hospital per pazienti depressi “difficili” da trattare. 254
Bipolar Disorder Questionnaire for the Assessment of Learning: a New Instrument for Studying Information Acquisition in Psychoeducational programs. 243
Neuroendocrinologia dei disturbi dell umore 243
Cognitive markers of psychotic unipolar depression: A meta-analytic study 238
Plasma magnesium level and psychomotor retardation in major depressed patients 223
Augmentation of drug treatment with bright light therapy in patients with difficult-to-treat depression: acute and long term observation 223
Dopamine transporter availability and psychomotor retardation in major depression 219
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 218
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 214
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study] 211
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. 211
Predicting treatment outcome in difficult-to-treat depressed patients 204
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. 198
Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation 198
[Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study]. 197
Problematic mobile phone use in adolescence: A cross-sectional study 196
A day treatment programme on mood disorders: One-year activity outcomes 193
Sexual Behavior in Women with Bipolar Disorder 189
Plasma magnesium levels and treatment outcome in depressed patients 188
Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up 187
Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms 183
Internet addiction: hours spent online, behaviors and psychological symptoms 180
Treatment of prurigo nodularis with pregabalin. 180
Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients 179
Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: depression vs. sub-threshold mixed state 178
An observational study evaluating comorbidity between bipolar disorder and personality disorders 174
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 174
Alcohol protracted withdrawal syndrome: the role of anhedonia 172
Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients 168
Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. 167
Plasma magnesium levels and treatment outcome in depressed patients 167
Polysomnographic Findings in a Cohort of Chronic Insomnia Patients with Benzodiazepines Abuse 167
Cognitive markers of psychotic unipolar depression: A meta-analytic study 167
Role of substance abuse comorbidity and personality on the outcome of depression in bipolar disorder: harm avoidance influences medium-term treatment outcome 164
Changing of dopamine transporter binding in depressed patients with anhedonia during treatment 164
Changes of Dopamine Transporter Availability in Depressed Patients with and without Anhedonia: A 123I-N-ω-Fluoropropyl-Carbomethoxy-3β-(4-Iodophenyl)tropane SPECT Study 164
Anhedonia and Cortisol Levels in Major Depression. 162
Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up 161
Behavioural addictions in adolescents and young adults: results from a prevalence study. 160
Psicopatologia nell’epilessia e nella pseudoepilessia: risultati preliminari nella nostra esperienza 159
Affective temperament and attachment in adulthood in patients with Bipolar Disorder and Cyclothymia 156
Mood, hormones and quality of life. 155
Somatic symptoms and high-sensitive C-reactive protein in major depression 155
Il trattamento della schizofrenia 155
Oxcarbazepine in bipolar disorder: a critical review of the literature 153
Hyperactivation of inflammatory response in depressed patients with psychomotor retardation 151
Striatal dopamine transporter density in anhedonic depressed patients before and after pharmachological treatment 151
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 151
Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients 151
Affective temperaments and psychopathological dimensions of personality in Bipolar Disorder 149
Clinical correlates of difficult-to-treat depression: Exploring an integrated day-care model of treatment 149
Treatment of prurigo nodularis with pregabalin 148
Facial emotion recognition deficit in Amnestic Mild Cognitive Impairment and Alzheimer Disease 148
Behavioural addictions in adolescents and young adults: results from a prevalence study 148
What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia? 147
Predictive value of magnesium levels in depressed patients. 147
Depression and suicide in epilepsy: Fact or artefact? 144
Duloxetine for premenstrual dysphoric disorder: a pilot study 144
Plasma dehydroepiandrosterone sulphate (DHEAS) and cortisol in patients with mood disorders 144
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables 143
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 143
La gestione della crisi suicidaria: dall'emergenza clinica alla riabilitazione del paziente 138
Enhanced BDNF serum levels in patients with severe pathological gambling 137
Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. 137
Analisi antropofenomenologica di un'esperienza in un'istituzione manicomiale del meridione 136
Cocaine use disorders and serum magnesium profile 136
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview 135
Oxcarbazepine improves mood in patients with epilepsy 134
Venlafaxine: Successful treatment in impulsive disorders 134
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. 134
Plasma levels of n-3 fatty acids in bipolar patients: Deficit restricted to DHA 134
Neuroendocrinology of mood disorders. 133
Inflammatory response and psychopathological dimensions in major depression 133
Oxcarbazepine improves mood in patients with epilepsy. 132
Evidenze preliminari sulle modifiche del transporter della dopamina in pazienti depressi con rallentamento psicomotorio 132
Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers 131
Ansia, depressione ed epilessia del lobo temporale 130
Major depressive disorder and dopamine transporter density: investigation by 123I-FP-CIT SPET 129
Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. 128
Sleep Disturbances and Depression: a review 127
Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. 125
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. 122
Enhanced BDNF serum levels in patients with severe pathological gambling 122
Functional neuroimaging: points of intersection between biology and psychotherapy. 121
Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions 119
Reply to Dr Korczyn. 118
Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. 115
Relating with migrants: ethnopsychiatry and psychotherapy 115
Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients 115
Reply to Dr Corrao and colleagues. 112
DAT binding and psychopathological features in depressed patients. 112
To be or not to be a bipolar disorder patient: problems with diagnosis. 110
Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms 110
Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles. 109
Efficacy and safety of pregabalin in alcohol dependence 109
Totale 16.396
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.415
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.102 109 135 19 61 40 26 34 193 40 70 169 206
2022/20232.407 297 362 160 409 196 273 121 161 297 22 74 35
2023/20241.003 48 303 23 44 37 112 42 34 35 51 154 120
2024/20252.265 120 108 159 117 208 90 49 149 351 189 388 337
2025/20265.286 807 132 290 540 985 262 901 276 340 432 190 131
2026/2027176 176 0 0 0 0 0 0 0 0 0 0 0
Totale 18.022